Vibroacoustic Therapy (VAT) is performed by transferring amplified sound directly to the human body through loudspeakers or transducers that are embedded in a bed or vibrotactile device.

     The innovative therapy was introduced by Norwegian musician/researcher, Olav Skille, in 1982. VAT utilizes electronically-generated low frequency tones (generally in the 30-120 Hz range), usually mixed with synthesized music, to treat a variety of conditions. 

     Institutions worldwide, that utilize VAT, collectively have more than 40,000 hours of experience.